Sunil Healthcare Ltd

₹ 73.5 0.00%

18 Sep - close price

sunilhealthcare.com BSE: 537253 NSE: SUNLOC

About

Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.^[1]

Key Points

Business Overview:^[1]^[2]
a) SHL was earlier engaged in trading (including merchant trading) agro based commodities, under brand Sunloc foods However, this was discontinued in FY20
b) Currently, it is mainly engaged in the manufacturing empty hard gelatin capsule (EHGC) shells and hydroxypropyl methyl cellulose (HPMC) and the choice in 9 sizes available are 00, 0SEL, 0EL, 0,1, 2, 3, 4, 5.
c) The company is a Hard-shell capsule manufacturer in India and pioneer in double lock and triple lock technology for capsules in India.
d) The company is WHO-GMP certified company and has also been recognized as Star Export House by GOI.

Website BSE NSE

Market Cap ₹ 75.4 Cr.
Current Price ₹ 73.5
High / Low ₹ 84.8 / 56.4
Stock P/E 16.8
Book Value ₹ 66.1
Dividend Yield 0.00 %
ROCE 6.51 %
ROE 5.50 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Stock is trading at 1.11 times its book value
Company's working capital requirements have reduced from 23.7 days to 14.4 days

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -0.49% over past five years.
Company has a low return on equity of 1.05% over last 3 years.
Company has high debtors of 182 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	22.13	23.58	22.67	21.31	21.50	20.26	20.46	21.20	22.64	23.52	21.84	19.72	18.99
	21.06	22.39	23.31	18.64	18.55	17.38	17.33	18.29	19.36	19.59	18.21	16.60	16.01
Operating Profit	1.07	1.19	-0.64	2.67	2.95	2.88	3.13	2.91	3.28	3.93	3.63	3.12	2.98
OPM %	4.84%	5.05%	-2.82%	12.53%	13.72%	14.22%	15.30%	13.73%	14.49%	16.71%	16.62%	15.82%	15.69%
	0.82	0.33	2.97	0.57	0.10	0.19	0.55	0.50	0.23	0.21	0.35	-9.23	0.23
Interest	1.27	1.31	1.44	1.76	1.51	1.50	1.89	1.56	1.44	1.40	1.66	1.66	1.50
Depreciation	1.61	1.59	1.45	1.43	1.48	1.51	1.69	1.68	1.66	1.64	1.62	1.52	1.46
Profit before tax	-0.99	-1.38	-0.56	0.05	0.06	0.06	0.10	0.17	0.41	1.10	0.70	-9.29	0.25
Tax %	-23.23%	-26.81%	-33.93%	20.00%	66.67%	66.67%	200.00%	-47.06%	29.27%	28.18%	37.14%	-26.48%	-104.00%
	-0.76	-1.02	-0.37	0.04	0.01	0.03	-0.09	0.25	0.29	0.79	0.44	-6.82	0.51
EPS in Rs	-0.74	-0.99	-0.36	0.04	0.01	0.03	-0.09	0.24	0.28	0.77	0.43	-6.65	0.50
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	72.64	81.63	108.95	90.22	80.93	70.13	89.89	116.37	111.83	89.69	83.42	87.72	84.07
	60.57	66.75	93.21	75.52	68.45	76.58	83.68	98.55	92.52	85.24	71.45	73.76	70.41
Operating Profit	12.07	14.88	15.74	14.70	12.48	-6.45	6.21	17.82	19.31	4.45	11.97	13.96	13.66
OPM %	16.62%	18.23%	14.45%	16.29%	15.42%	-9.20%	6.91%	15.31%	17.27%	4.96%	14.35%	15.91%	16.25%
	0.94	1.33	1.25	2.00	0.09	14.71	5.56	1.55	1.63	4.53	1.25	-8.44	-8.44
Interest	2.85	4.36	4.18	5.03	6.58	6.95	5.31	3.49	4.17	5.78	6.46	6.16	6.22
Depreciation	4.00	3.82	4.33	4.78	5.74	6.13	6.11	6.31	7.01	6.08	6.35	6.44	6.24
Profit before tax	6.16	8.03	8.48	6.89	0.25	-4.82	0.35	9.57	9.76	-2.88	0.41	-7.08	-7.24
Tax %	35.39%	34.99%	33.73%	22.64%	28.00%	-13.49%	22.86%	29.15%	28.48%	-27.08%	48.78%	-25.00%
	3.98	5.23	5.62	5.32	0.18	-4.17	0.28	6.78	6.98	-2.11	0.21	-5.30	-5.08
EPS in Rs	3.88	5.10	5.48	5.19	0.18	-4.07	0.27	6.61	6.81	-2.06	0.20	-5.17	-4.95
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	1%
5 Years:	0%
3 Years:	-8%
TTM:	-1%

Compounded Profit Growth
10 Years:	-3%
5 Years:	65%
3 Years:	-17%
TTM:	838%

Stock Price CAGR
10 Years:	-2%
5 Years:	15%
3 Years:	12%
1 Year:	-10%

Return on Equity
10 Years:	4%
5 Years:	5%
3 Years:	1%
Last Year:	6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.25	10.25	10.25	10.25	10.25	10.25	10.25	10.25	10.25	10.25	10.25	10.25
Reserves	15.62	20.81	33.24	38.54	38.88	37.52	37.82	44.53	51.47	63.79	63.40	57.58
	25.16	37.06	44.53	60.62	55.08	49.45	49.82	34.68	36.79	66.15	68.65	55.79
	12.51	17.66	31.33	33.18	35.50	37.19	25.68	22.73	27.57	23.70	25.91	38.70
Total Liabilities	63.54	85.78	119.35	142.59	139.71	134.41	123.57	112.19	126.08	163.89	168.21	162.32
	27.31	40.94	59.72	70.92	68.82	69.97	69.80	69.97	70.43	87.16	94.08	85.85
CWIP	0.77	0.06	0.12	0.19	2.47	0.01	0.01	1.75	0.01	5.66	0.09	1.77
Investments	0.00	0.00	0.00	0.23	0.24	0.24	1.20	1.16	0.00	0.00	0.00	0.00
	35.46	44.78	59.51	71.25	68.18	64.19	52.56	39.31	55.64	71.07	74.04	74.70
Total Assets	63.54	85.78	119.35	142.59	139.71	134.41	123.57	112.19	126.08	163.89	168.21	162.32

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5.88	7.77	10.79	4.91	15.07	4.18	16.63	21.89	7.13	-14.35	11.54	22.15
	-8.48	-14.90	-12.85	-17.36	-3.08	-2.46	-11.33	-3.35	-3.40	-10.62	-7.70	-2.85
	2.75	8.18	2.23	11.62	-11.66	-1.54	-6.42	-18.56	-3.75	25.00	-3.87	-19.26
Net Cash Flow	0.15	1.05	0.17	-0.83	0.33	0.18	-1.12	-0.01	-0.02	0.04	-0.03	0.04
Free Cash Flow	-1.93	-6.69	-2.15	-10.75	9.56	3.50	9.92	12.87	3.65	-24.53	2.54	18.60
CFO/OP	75%	65%	79%	43%	123%	-66%	265%	129%	44%	-305%	96%	159%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	99.39	107.94	130.49	194.11	186.63	149.01	112.84	69.00	115.90	192.37	212.21	181.79
Inventory Days	109.32	134.28	74.03	98.26	185.09	283.19	95.96	76.84	97.03	98.42	162.94	216.53
Days Payable	80.62	106.03	137.66	180.38	280.22	297.33	107.97	64.07	112.06	44.74	83.51	180.82
Cash Conversion Cycle	128.09	136.18	66.86	111.99	91.50	134.87	100.83	81.77	100.87	246.04	291.63	217.50
Working Capital Days	6.93	-6.57	-9.65	-11.00	-40.23	-46.79	-34.72	-11.07	16.25	30.24	26.38	14.36
ROCE %	19.19%	20.80%	16.37%	12.08%	6.39%	2.38%	5.84%	13.88%	14.73%	2.57%	4.93%	6.51%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Installed Capacity
Million capsules p.a.

x,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
xx.xx		xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx		xx.xx	xx.xx	xx.xx	xx.xx
x,xxx	x,xxx	x,xxx	x,xxx	xx,xxx

Please log in to see hidden values.

Export Revenue
% of total revenue

Top 5 Customer Concentration
% of total revenue

Production Volume
Million capsules

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%
	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%
	26.37%	26.37%	26.35%	26.37%	26.36%	26.37%	26.36%	26.38%	26.37%	26.36%	26.37%	26.37%
No. of Shareholders	7,081	7,010	6,858	6,594	6,507	6,550	6,541	6,475	6,430	6,399	6,364	6,310

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%	73.53%
	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%
	26.37%	26.37%	26.37%	26.37%	26.37%	26.37%	26.36%	26.35%	26.36%	26.37%	26.37%
No. of Shareholders	6,831	6,545	6,383	6,451	6,307	6,441	7,111	6,858	6,541	6,364	6,310

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

Nov 2018

Transcript

AI Summary
PPT
Sep 2018

Transcript

AI Summary
PPT
May 2018

Transcript

AI Summary
PPT
May 2018

Transcript

AI Summary
PPT
Feb 2018

Transcript

AI Summary
PPT
Feb 2018

Transcript

AI Summary
PPT
Dec 2017

Transcript

AI Summary
PPT
Aug 2017

Transcript

AI Summary
PPT
May 2017

Transcript

AI Summary
PPT
Feb 2017

Transcript

AI Summary
PPT
Nov 2016

Transcript

AI Summary
PPT
Aug 2016

Transcript

AI Summary
PPT
May 2016

Transcript

AI Summary
PPT
Mar 2016

Transcript

AI Summary
PPT